Cambridge, Massachusetts-based iTeos Therapeutics, a developer of cancer immunotherapies, has raised $125 million in Series B2 financing. RA Capital Management and Boxer Capital led the round.
Source: Press Release
iTeos Therapeutics racks up $125m
Cambridge, Massachusetts-based iTeos Therapeutics, a developer of cancer immunotherapies, has raised $125 million in Series B2 financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: